Investigator
Jian Hu
EMORY UNIVERSITY · funded by NIGMS, NCATS, NINDS
- Companies
- 1
- Grants
- 10
- Non-dilutive funding
- $3.4M
- First award
- Aug 28, 1996
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- PUMPKINSEED TECHNOLOGIES INC41momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R35
Statistical approaches for integrating multi-view, multi-section and multi-sample spatial transcriptomics data to decipher disease mechanisms
$385kSep 1, 2025NIGMSEMORY UNIVERSITYNIH RePORTER · 11201074 (opens the source filing in a new tab)
- R03
Screening Variants of Unknown Significance to Identify Pathogenic Variants of the Manganese Transporter SLC39A8
$148kJun 1, 2025NCATSMICHIGAN STATE UNIVERSITYNIH RePORTER · 11137166 (opens the source filing in a new tab)
- R01
The role of membrane homoeostasis of neural stem cell and glioma stem cells in neural development and gliomagenesis
$418kAug 21, 2023NINDSUNIVERSITY OF TX MD ANDERSON CAN CTRNIH RePORTER · 11097256 (opens the source filing in a new tab)
- R01
The role of membrane homoeostasis of neural stem cell and glioma stem cells in neural development and gliomagenesis
$422kAug 21, 2023NINDSUNIVERSITY OF TX MD ANDERSON CAN CTRNIH RePORTER · 11334282 (opens the source filing in a new tab)
- R01
Promoting remyelination in multiple sclerosis by simultaneously modulating myelin debris clearance and myelin lipid synthesis
$435kJul 15, 2022NINDSUNIVERSITY OF TX MD ANDERSON CAN CTRNIH RePORTER · 11123090 (opens the source filing in a new tab)
- R01
Promoting remyelination in multiple sclerosis by simultaneously modulating myelin debris clearance and myelin lipid synthesis
$435kJul 15, 2022NINDSUNIVERSITY OF TX MD ANDERSON CAN CTRNIH RePORTER · 11330502 (opens the source filing in a new tab)
- R01
Investigating the role of dysfunctional histone H3.3 in driving early neuronal development and pediatric high-grade gliomas
$301kJun 1, 2021NINDSUNIVERSITY OF TX MD ANDERSON CAN CTRNIH RePORTER · 11097333 (opens the source filing in a new tab)
- R35
Transport, substrate specificity and regulation mechanisms of the ZIP transition metal transporters
$390kMay 1, 2021NIGMSMICHIGAN STATE UNIVERSITYNIH RePORTER · 11077248 (opens the source filing in a new tab)
- P50
Project 2: Restore Myeloid Phagocytosis in Glioblastoma by Targeting the QKI/PPARb/RXRa Complex
$328kSep 1, 2008NCIUNIVERSITY OF TX MD ANDERSON CAN CTRNIH RePORTER · 11193448 (opens the source filing in a new tab)
- P30
06 High Resolution Electron Microscopy Facility
$186kAug 28, 1996NCIUNIVERSITY OF TX MD ANDERSON CAN CTRNIH RePORTER · 11146738 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources